Xilio Therapeutics Inc. (XLO)
1.08
0.00 (0.00%)
At close: Jan 15, 2025, 12:35 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -76.40M | -88.22M | -75.80M | -55.22M | -17.31M |
| Depreciation & Amortization | 1.90M | 1.85M | 1.50M | 1.06M | 240.00K |
| Stock-Based Compensation | 7.38M | 8.42M | 4.96M | 1.30M | 112.00K |
| Other Working Capital | 2.47M | 1.52M | -8.98M | 13.68M | -173.00K |
| Other Non-Cash Items | -3.97M | 224.00K | 173.00K | 39.00K | 56.00K |
| Deferred Income Tax | 2.06M | n/a | 222.00K | 126.00K | -1.74M |
| Change in Working Capital | 405.00K | 2.00M | -11.80M | 16.60M | 797.00K |
| Operating Cash Flow | -68.62M | -75.72M | -80.75M | -36.09M | -17.84M |
| Capital Expenditures | -486.00K | -1.87M | -1.10M | -2.19M | -715.00K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -486.00K | -1.87M | -1.10M | -2.19M | -715.00K |
| Debt Repayment | -6.75M | -85.00K | -110.00K | -99.00K | 9.95M |
| Common Stock Repurchased | 194.00K | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 202.00K | 16.00K | 144.42M | 10.13M | 40.12M |
| Financial Cash Flow | -6.55M | -69.00K | 260.67M | 10.03M | 60.02M |
| Net Cash Flow | -75.66M | -77.66M | 178.82M | -28.25M | 41.46M |
| Free Cash Flow | -69.11K | -77.59M | -81.85M | -38.28M | -18.56M |